Il-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance

Mediators of Inflammation

Volumn 2011, Issue , 2011, Pages

  Batetta, Barbara ^a   Fulghesu, Anna M ^a   Sanna, Francesca ^a   Uda, Sabrina ^a   Magnini, Roberta ^a   Portoghese, Elaine ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; BIOLOGICAL MARKER; CHOLESTEROL;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; LYMPHOCYTE; MONOCYTE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BIOSYNTHESIS; BLOOD; CHEMISTRY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADOLESCENT; BIOLOGICAL MARKERS; CHOLESTEROL; FEMALE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 79955019846     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2011/389317     Document Type: Article

References (54)

1. Franks S., Polycystic ovary syndrome: a changing perspective Clinical Endocrinology 1989 31 1 87 120 (Pubitemid 19178148)
2. Shroff R., Kerchner A., Maifeld M., Van Beek E. J. R., Jagasia D., Dokras A., Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis Journal of Clinical Endocrinology and Metabolism 2007 92 12 4609 4614 (Pubitemid 350223434)
3. Talbott E. O., Guzick D. S., Sutton-Tyrrell K., McHugh-Pemu K. P., Zborowski J. V., Remsberg K. E., Kuller L. H., Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 11 2414 2421
4. Christian R. C., Dumesic D. A., Behrenbeck T., Oberg A. L., Sheedy P. F., Fitzpatrick L. A., Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 2003 88 6 2562 2568 (Pubitemid 36724424)
5. Orio Jr. F., Palomba S., Spinelli L., Cascella T., Tauchmanov L., Zullo F., Lombardi G., Colao A., The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study Journal of Clinical Endocrinology and Metabolism 2004 89 8 3696 3701 (Pubitemid 39071458)
6. Giallauria F., Orio F., Palomba S., Lombardi G., Colao A., Vigorito C., Cardiovascular risk in women with polycystic ovary syndrome Journal of Cardiovascular Medicine 2008 9 10 987 992
7. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 (Pubitemid 38766330)
8. Puder J. J., Varga S., Kraenzlin M., De Geyter C., Keller U., Mller B., Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance Journal of Clinical Endocrinology and Metabolism 2005 90 11 6014 6021 (Pubitemid 41606519)
9. Tarkun I., Arslan B. C., Cantrk Z., Tremen E., ahin T., Duman C., Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation Journal of Clinical Endocrinology and Metabolism 2004 89 11 5592 5596 (Pubitemid 39518445)
10. Benson S., Janssen O. E., Hahn S., Tan S., Dietz T., Mann K., Pleger K., Schedlowski M., Arck P. C., Elsenbruch S., Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome Brain, Behavior, and Immunity 2008 22 2 177 184 (Pubitemid 350299801)
11. Boulman N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O., Blumenfeld Z., Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease Journal of Clinical Endocrinology and Metabolism 2004 89 5 2160 2165 (Pubitemid 38619847)
12. Vgontzas A. N., Trakada G., Bixler E. O., Lin H. M., Pejovic S., Zoumakis E., Chrousos G. P., Legro R. S., Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea Metabolism 2006 55 8 1076 1082 (Pubitemid 44026546)
13. Rouru J., Anttila L., Koskinen P., Penttil T. A., Irjala K., Huupponen R., Koulu M., Serum leptin concentrations in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 1997 82 6 1697 1700 (Pubitemid 127495171)
14. Gennarelli G., Holte J., Wide L., Berne C., Lithell H., Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Human Reproduction 1998 13 3 535 541 (Pubitemid 28171941)
15. Jacobs H. S., Conway G. S., Leptin, polycystic ovaries and polycystic ovary syndrome Human Reproduction Update 1999 5 2 166 171 (Pubitemid 29201885)
16. Yildirim B., Sabir N., Kaleli B., Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome Fertility and Sterility 2003 79 6 1358 1364 (Pubitemid 36687882)
17. Orio F. Jr., Palomba S., Cascella T., Milan G., Mioni R., Pagano C., Zullo F., Colao A., Lombardi G., Vettor R., Adiponectin levels in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 2003 88 6 2619 2623 (Pubitemid 36724434)
18. Panidis D., Kourtis A., Farmakiotis D., Mouselech T., Rousso D., Koliakos G., Serum adiponectin levels in women with polycystic ovary syndrome Human Reproduction 2003 18 9 1790 1796 (Pubitemid 37107549)
19. Fulghesu A. M., Angioni S., Portoghese E., Milano F., Batetta B., Paoletti A. M., Melis G. B., Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome Fertility and Sterility 2006 86 2 398 404 (Pubitemid 44118963)
20. Karadeniz M., Erdoan M., Tamsel S., Zengi A., Alper G. E., alayan O., Saygili F., Yilmaz C., Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances Experimental and Clinical Endocrinology and Diabetes 2008 116 4 231 235 (Pubitemid 351600585)
21. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Human Reproduction 2004 19 1 41 47
22. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 1979 28 1039 1057
23. Jones N. H., Finding the area under the curve using jmp and a trapezoidal rule. SAS Institute, Cary, NC, USA, 1997
24. Carmina E., Lobo R. A., Use of fasting blood to assess the prevalence of insulin resistence in women with polycystic ovarian syndrome Fertility and Sterility 2004 82 661 665 (Pubitemid 39243189)
25. Lanzone A., Fulghesu A. M., Cucinelli F., Ciampelli M., Caruso A., Mancuso S., Evidence of distinct rearrangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinising hormone secretion Journal of Clinical Endocrinology Metabolism 1995 80 3501 3506
26. Mantovani G., Macci A., Esu S., Lai P., Santona M. C., Massa E., Dessi D., Melis G. B., Del Giacco G. S., Medroxyprogesterone acetate reduces the In vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients European Journal of Cancer Part A 1997 33 4 602 607 (Pubitemid 27223745)
27. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
28. Sanna F., Bonatesta R. R., Frongia B., Uda S., Banni S., Melis M. P., Collu M., Madeddu C., Serpe R., Puddu S., Porcu G., Dess S., Batetta B., Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects Journal of Vascular Research 2007 44 4 253 263 (Pubitemid 46956828)
29. Bonatesta R. R., Sanna F., Uda S., Frongia B., Pintus S., Pintus P., Collu M., Saddi A., Batetta B., Inhibition of cholesterol esterification influences cytokine exspression in lypopolisaccharide-activated P388D1 macrophages American Journal of Infectious Diseases 2007 3 3 151 158
30. Cook S., Weitzman M., Auinger P., Nguyen M., Dietz W. H., Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 19881994 Archives of Pediatrics and Adolescent Medicine 2003 157 8 821 827 (Pubitemid 36988016)
31. Carmina E., Bucchieri S., Esposito A., Del Puente A., Mansueto P., Orio F., Di Fede G., Rini G., Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance Journal of Clinical Endocrinology and Metabolism 2007 92 7 2500 2505 (Pubitemid 47037349)
32. Lo J. C., Feigenbaum S. L., Yang J., Pressman A. R., Selby J. V., Go A. S., Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 2006 91 4 1357 1363
33. Dahlgren E., Janson P. O., Johansson S., Lapidus L., Oden A., Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women Acta Obstetricia et Gynecologica Scandinavica 1992 71 8 599 604 (Pubitemid 23050339)
34. Wild S., Pierpoint T., Jacobs H., McKeigue P., Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study Human Fertility 2000 3 2 101 105
35. Samy N., Hashim M., Sayed M., Said M., Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index Disease Markers 2009 26 4 163 170
36. Kelly C. C. J., Lyall H., Petrie J. R., Gould G. W., Connell J. M. C., Sattar N., Low grade chronic inflammation in women with polycystic ovarian syndrome Journal of Clinical Endocrinology and Metabolism 2001 86 6 2453 2455 (Pubitemid 32545690)
37. Fenkci V., Fenkci S., Yilmazer M., Serteser M., Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease Fertility and Sterility 2003 80 1 123 127 (Pubitemid 36808867)
38. Antuna-Puente B., Feve B., Fellahi S., Bastard J. P., Adipokines: the missing link between insulin resistance and obesity Diabetes and Metabolism 2008 34 1 2 11
39. Casas J. P., Shah T., Hingorani A. D., Danesh J., Pepys M. B., C-reactive protein and coronary heart disease: a critical review Journal of Internal Medicine 2008 264 4 295 314
40. Ibez L., Jaramillo A. M., Ferrer A., de Zegher F., High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception Human Reproduction 2005 20 9 2457 2462 (Pubitemid 41226405)
41. Lee S., Bacha F., Gungor N., Arslanian S., Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers Journal of Pediatrics 2008 152 2 177 e3
42. Carmina E., Legro R. S., Stamets K., Lowell J., Lobo R. A., Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet Human Reproduction 2003 18 11 2289 2293 (Pubitemid 37427805)
43. Carmina E., Napoli N., Longo R. A., Rini G. B., Lobo R. A., Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS European Journal of Endocrinology 2006 154 1 141 145 (Pubitemid 43250748)
44. O'Connor A., Phelan N., Tun T. K., Boran G., Gibney J., Roche H. M., High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance Journal of Clinical Endocrinology and Metabolism 2010 95 3 1378 1385
45. Bideci A., amurdan M. O., Yeilkaya E., Demirel F., Cinaz P., Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome Journal of Obstetrics and Gynaecology Research 2008 34 4 578 584
46. Sathyapalan T., Atkin S. L., Mediators of inflammation in polycystic ovary syndrome in relation to adiposity Mediators of Inflammation 2010 2010 5
47. Garruti G., Depalo R., Vita M. G., Lorusso F., Giampetruzzi F., Damato A. B., Giorgino F., Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment Reproductive BioMedicine Online 2009 19 4 552 563
48. Godoy-Matos A. F., Vaisman F., Pedrosa A. P., Farias M. L. F., Mendona L. M. C., Pinheiro M. F. M. C., Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome Gynecological Endocrinology 2009 25 12 793 798
49. Araya A. V., Aguirre A., Romero C., Miranda C., Molina M. C., Ferreira A., Evaluation of tumor necrosis factor alpha production in ex vivo short term cultured whole blood from women with polycystic ovary syndrome European Cytokine Network 2002 13 4 419 424 (Pubitemid 36174099)
50. Abeywardena M. Y., Leifert W. R., Warnes K. E., Varghese J. N., Head R. J., Cardiovascular biology of interleukin-6 Current Pharmaceutical Design 2009 15 15 1809 1821
51. Medzhitov R., Origin and physiological roles of inflammation Nature 2008 454 7203 428 435
52. Packard R. R. S., Lichtman A. H., Libby P., Innate and adaptive immunity in atherosclerosis Seminars in Immunopathology 2009 31 1 5 22
53. Moutsopoulos N. M., Madianos P. N., Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections Annals of the New York Academy of Sciences 2006 1088 251 264 (Pubitemid 47092053)
54. Wiedermann C. J., Kiechl S., Dunzendorfer S., Schratzberger P., Egger G., Oberhollenzer F., Willeit J., Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study Journal of the American College of Cardiology 1999 34 7 1975 1981 (Pubitemid 30002653)